Stephen R. Brady - 03 Jan 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Executive Officer, Director
Signature
/s/ Stephen R. Brady
Issuer symbol
TPST
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 19:00:46 UTC
Previous filing
22 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +177,300 $0.000000 177,300 03 Jan 2023 Common Stock 177,300 $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.